GlassScriptPhysician profile
Jay Yogesh Darji
NPI 1144881830
$7,003.31
in general payments reported to CMS, 2019-2025
12 companies · $683 in 2025
The $683 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $167 · 2023: $4,316 · 2024: $1,838 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,167 · Food and Beverage: $2,039 · Travel and Lodging: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,166.67 |
| Food and Beverage | $2,039.15 |
| Travel and Lodging | $1,630.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,893.18 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic, INC. | $1,919.99 | 2023-2024 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $1,522.50 | 2023-2025 | Eterna |
| Collegium Pharmaceutical, INC. | $145.63 | 2024-2025 | Belbuca |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Vertos Medical, INC. | $116.03 | 2024 | Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $86.94 | 2022 | |
| Merz Pharmaceuticals, LLC | $79.56 | 2022 | |
| Globus Medical, INC. | $57.41 | 2025 | Senza |
| Depuy Synthes Sales INC. | $28.27 | 2025 | Orthovisc, Monovisc |
| Appliedvr INC | $20.33 | 2025 | Relievrx |
| Piramal Critical Care | $16.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Darji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.